Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / India's Serum Institute signs COVID-19 vaccine deal with America's Novavax
  • Business

    India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

    Shubham Sharma
    Written by
    Shubham Sharma
    Twitter
    Last updated on Aug 06, 2020, 01:42 pm
    India's Serum Institute signs COVID-19 vaccine deal with America's Novavax
  • Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

    The Adar Poonawalla-led company, which is already in the process of bringing Oxford and AstraZeneca's ChAdOx1 vaccine to the country, has signed a deal to locally manufacture and commercialize Novavax's shot once it is ready and proven effective.

    Here's all you need to know about it.

  • In this article
    Supply and License agreement between the two organizations SII will source key components from Novavax, share revenue Agreement excludes rich countries Vaccine proven effective in early-stage trials How it works in the human body? Late-stage trials might begin next month
  • Agreement

    Supply and License agreement between the two organizations

  • In a recent filing with the US Securities and Exchange Commission, Novavax said that it has entered a "supply and license agreement" with the SII.

    Under this deal, the company said it will give the Indian organization exclusive and non-exclusive licenses for the "development, co-formulation, filling and finishing, registration and commercialization" of its NVX-CoV2373 vaccine candidate for the SARS-CoV-2 virus.

  • Information

    SII will source key components from Novavax, share revenue

  • The filing notes that SII will source two key components from Novavax to start manufacturing NVX-CoV2373 - the antigen drug substance and Matrix-M adjuvant. Also, once it starts selling the shot in India (post approvals), both the parties will equally share the generated revenue.

  • Terms

    Agreement excludes rich countries

    Agreement excludes rich countries
  • Notably, under the terms, Novavax has given exclusive rights to SII for its COVID-19 vaccine in India during the term of the deal - 15 years - as well as non-exclusive rights during the "Pandemic Period" in all countries, except those designated by the World Bank as upper-middle/high-income countries.

    For these rich countries, the company said it retains the right for the vaccine.

  • Effectiveness

    Vaccine proven effective in early-stage trials

  • The deal between the SII and Novavax was struck just a few days before the latter announced promising results from the Phase-1 clinical trial of its COVID-19 vaccine.

    According to the data, the shot in question was able to induce a high level of neutralizing antibodies in all 131 of the study participants, without any major side effects.

  • Working

    How it works in the human body?

    How it works in the human body?
  • The Novavax vaccine is a stable, prefusion protein that sends harmless copies of the coronavirus spike protein in the patient's body to train their immune system to fight off the actual infection when needed.

    According to the Associated Press, the company's scientists extracted the actual spike protein, purified it, and then packaged it into virus-sized nanoparticles to create the delivery shot.

  • Information

    Late-stage trials might begin next month

  • Currently, the NVX-CoV2373 vaccine, which has been backed by the US government, is in the Phase-2 of human trials. It is expected to move into a larger Phase-3 by the end of September and become available by the end of 2020.

  • India
  • Oxford
  • World Bank
  • Associated Press
  • US Securities and Exchange Commission
  •  
Latest News
  • NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    Science
  • PUBG: New State announced for iOS, Android; Unavailable in India
    PUBG: New State announced for iOS, Android; Unavailable in India
    Science
  • Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Entertainment
  • Google integrates lightweight HTML5 games into Chrome browser on Android
    Google integrates lightweight HTML5 games into Chrome browser on Android
    Science
  • Sony announces next-generation PSVR headset for the PlayStation 5
    Sony announces next-generation PSVR headset for the PlayStation 5
    Science
Related Timelines
  • Google's US office facilities will serve as COVID-19 vaccination clinics
    Google's US office facilities will serve as COVID-19 vaccination clinics
    Business
  • Rs. 200 per vaccine dose: SII receives government's purchase order
    Rs. 200 per vaccine dose: SII receives government's purchase order
    India
  • SII to sue vaccine trial participant for Rs. 100 crore
    SII to sue vaccine trial participant for Rs. 100 crore
    Science
  • Can launch 100 million vaccine doses by January-February, says Poonawalla
    Can launch 100 million vaccine doses by January-February, says Poonawalla
    Science
Trending Topics
Bharti Airtel Mukesh Ambani WhatsApp Reliance Jio OPPO Isha Ambani
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Rahul Gandhi Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics
Avengers Neha Kakkar Premier League Big Bang Theory
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021